Singapore to Subsidise HPV9 Vaccine From 2027
From 1 January 2027, Singapore will add the HPV9 vaccine to national immunisation schedules and subsidised vaccine support, expanding protection against cervical cancer.
Illustrative image | AI-generated for KnowvaLife
This article provides general health information and does not replace advice from a qualified healthcare professional. Eligibility, vaccine schedules and subsidies can depend on age, citizenship, residency and previous doses. Confirm your personal recommendations with a doctor or the relevant Singapore health authority.
HEALTH NEWS — Singapore will add the human papillomavirus 9-valent (HPV9) vaccine, also known as Gardasil 9, to the National Childhood Immunisation Schedule, National Adult Immunisation Schedule and Subsidised Vaccine List from 1 January 2027.
The Ministry of Health (MOH), Communicable Diseases Agency (CDA) and Health Promotion Board (HPB) announced the change on 2 October 2026. The policy is intended to give eligible residents broader protection against HPV types linked to cervical cancer.
From 1 January 2027, eligible Singaporean and Permanent Resident females aged 9 to 26 can follow the updated HPV9 recommendations. HPV9 will replace HPV2 for female students who have not started or completed their school-based vaccination series. HPV2 remains an alternative on the national schedules.
Why Is HPV9 Being Added?
HPV2 protects against HPV types 16 and 18, which cause about 70% of cervical cancers. HPV9 also covers additional cancer-causing types, increasing protection against the HPV types responsible for approximately 90% of cervical cancers.
HPV is common and often causes no symptoms. Most infections clear naturally, but persistent infection with high-risk HPV types can cause abnormal cell changes and, over time, cervical cancer.
HPV vaccination lowers the risk of cervical cancer but does not protect against every cancer-causing HPV type. Eligible women should continue regular cervical cancer screening according to Singapore’s recommendations.
Who Can Receive Subsidised HPV9 Vaccination?
From 1 January 2027, the updated national schedules will include HPV9 for females aged 9 to 26. Subsidy arrangements differ by age group and residency status; additional doses after a completed recommended series are not covered by this announcement.
Full subsidies for HPV9 at participating CHAS GP clinics and polyclinics.
Means-tested subsidies of up to 75% at participating CHAS GP clinics and polyclinics.
Subsidies will be available at polyclinics under the updated arrangements.
MediSave use will be extended to recommended groups, subject to the applicable annual limits.
MediSave can be used within the annual Chronic and Preventive Care limits of $700 or $1,000, depending on qualifying chronic disease care circumstances. These are annual scheme limits, rather than a separate HPV9 allowance. Ask the clinic to confirm your eligibility, remaining limit and any amount payable before booking.
What Happens to HPV2 and Earlier Doses?
HPV2, also known as Cervarix, will remain an alternative option on the national schedules. People who have started with HPV2 or the earlier HPV4 vaccine and are still waiting for further doses may complete the series with HPV9, based on the updated recommendations.
MOH says mixed HPV vaccination schedules have been studied and are safe, with protection against the HPV strains covered by both vaccines. People who have already completed their recommended HPV vaccination schedule are not advised to take additional HPV9 doses.
If you have completed the recommended HPV2, HPV4 or HPV9 series, do not assume that you need extra doses. Speak with a doctor if your vaccination record is incomplete or unclear.
How Many Doses Are Recommended?
Under the updated Expert Committee on Immunisation recommendations, the number of doses depends on the age at which the first dose is received.
- First dose at age 9 to 14: two doses are recommended.
- First dose at age 15 to 26: three doses are recommended.
- Started but not completed by age 26: remaining doses may be completed after age 26, as early as possible and up to age 45.
The exact interval between doses depends on the schedule and vaccine history. A clinic or doctor can confirm which dose is due and whether any previous dose counts.
What Changes in the School-Based Programme?
HPB currently offers HPV vaccination at no charge to Secondary 1 and Secondary 2 female students through the school-based programme. From 1 January 2027, HPV9 will replace HPV2 for female students who have not started or completed their series.
Female students who received HPV2 as their first dose in 2026—the 2026 Secondary 1 cohort—will be scheduled to complete their series in schools in 2027 with HPV9 as the second dose. Students who have already completed their recommended series are not eligible for additional HPV9 doses under the programme.
Where Can Eligible Residents Book?
The new HPV9 subsidy arrangements take effect on 1 January 2027. Eligible individuals can book at participating CHAS GP clinics through vaccine.gov.sg or make an appointment at a polyclinic. Healthier SG enrollees are encouraged to arrange vaccination at their enrolled clinic. Confirm HPV9 appointment availability and the applicable cost with the provider.
Bring any vaccination records you have. Tell the healthcare professional about previous HPV doses, serious allergies, pregnancy or plans for pregnancy, and any current moderate or severe illness.
What Protection Does HPV9 Provide?
Gardasil 9 protects against HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58. In addition to cervical cancer prevention, HPV vaccination can help prevent certain HPV-related vulvar, vaginal and anal cancers and genital warts, although the national recommendation and subsidy policy described by MOH is focused on females aged 9 to 26.
HPV vaccines are preventive vaccines. They do not treat an existing HPV infection or remove abnormal cells that are already present.
HPV vaccination provides primary prevention. Cervical screening helps find high-risk HPV infection or cell changes early, when follow-up and treatment can prevent cervical cancer from developing.
What Should Women Know About Cervical Screening?
HealthHub recommends regular cervical cancer screening even after HPV vaccination. For women aged 25 and above who have ever had sex, the general recommendation is a Pap test every three years at ages 25 to 29, or an HPV test every five years from age 30. Your doctor can advise on the appropriate test and interval based on your history and previous results.
Ask a healthcare professional which screening test is appropriate for you. Screening can detect changes before symptoms appear.
What Is Confirmed—and What Is Still Personal Advice?
The change to add HPV9 to Singapore’s schedules and subsidy support from 1 January 2027 is confirmed by MOH, CDA and HPB. Gardasil 9 is already available privately; the announcement concerns its inclusion in the national schedules and subsidy arrangements. The exact dose timing, clinic availability and out-of-pocket cost for an individual may depend on vaccination history, age, citizenship or residency and the clinic’s billing process.
This announcement does not mean every person needs a new or additional vaccine dose. People who have completed a recommended schedule are not advised to receive extra HPV9 doses solely because the vaccine is being added to the schedules.
Singapore’s HPV9 subsidy change is a practical opportunity for eligible families and adults to review their vaccination records. The key steps are to check previous doses, confirm eligibility with a participating clinic and continue regular cervical screening where recommended.
Key Takeaways
- HPV9 will be added to Singapore’s national immunisation schedules and Subsidised Vaccine List from 1 January 2027.
- HPV9 covers HPV types linked to approximately 90% of cervical cancers, compared with about 70% for HPV2.
- Eligible Singaporean children can receive full subsidies at participating CHAS GP clinics and polyclinics.
- Eligible Singaporean adults can receive means-tested subsidies of up to 75%; eligible PRs can receive subsidies at polyclinics.
- MediSave use will be extended for recommended groups, subject to the applicable annual limits.
- Female students in the school-based programme who received HPV2 in 2026 may complete the series with HPV9 in 2027.
- Two doses are recommended when the first dose is given at age 9 to 14; three doses are recommended when starting at age 15 to 26.
- People who have completed their recommended HPV vaccination course are not advised to take extra HPV9 doses.
- HPV vaccination does not replace regular cervical cancer screening.
Sources & References
- Singapore Ministry of Health, Communicable Diseases Agency and Health Promotion Board. HPV9 Vaccine Added to National Immunisation Schedules From January 2027. Published 2 October 2026.
- HealthHub Singapore. Preventing HPV infection: HPV vaccination. Accessed 6 October 2026.
- HealthHub Singapore. Human Papillomavirus (HPV) Vaccine. Accessed 6 October 2026.
- World Health Organization. Cervical cancer fact sheet. Accessed 6 October 2026.
- Health Promotion Board. Childhood Vaccination Costs. School-based HPV9 programme update. Accessed 6 October 2026.
About KnowvaLife
KnowvaLife explains health news and everyday health topics in simple, easy-to-understand language. We use reliable health sources to help readers understand important developments and make more informed health decisions.
